JPRN-jRCT1080222299未知4 期
Post-marketing Clinical Study of Onglyza Tablet
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2013年11月21日最近更新:
试验速览
- 阶段
- 4 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Subjects with a diagnosis of type 2 diabetes mellitus.
- •2) Subjects who have been undergoing dietary and exercise therapy and have not taken any oral antihyperglycemic medications for more than 12 weeks prior to initiation of study treatment.
排除标准
- •1) Subjects with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus.
研究者
相似试验
未知
4 期
Post-marketing clinical study of Ogamma 100 in patients with mycosis fungoidesMycosis fungoidesJPRN-jRCT1080220041Otsuka Pharmaceutical Co., Ltd.
未知
4 期
Post-marketing clinical study of Ogamma 100 in patients with adult T-cell leukemia (ATL)ATJPRN-jRCT1080220042Otsuka Pharmaceutical Co., Ltd.
未知
4 期
Post-Marketing Clinical Study of EPZICOM Tablet (Lamivudine / Abacavir Sulfate) -Pharmacokinetic Study in HIV-Infected PatientsHIV infectionJPRN-jRCT1080220286GlaxoSmithKline K.K.
已完成
不适用
Evaluation of the efficacy and safety of 5mg olanzapine combined with granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in thoracic tumor patients: a multicenter phase 2 studythoracic tumorJPRN-UMIN000031267Gifu University50
已完成
不适用
Evaluation of the efficacy and safety of 5mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in gynecologic cancer patients: a multicenter phase 2 study.gynecologic cancerJPRN-UMIN000031646Gifu University60